Melanoma
Researchers publish new studies and findings in the area of melanoma
Published in Gene Therapy Weekly, October 13th, 2005
Study 1: Glutathione-S-transferase Pi1 (GSTP1) and multidrug resistance protein 1 (MRP1) combine to resist melanoma treatment.
According to recent research published in the British Journal Of Cancer, "GSTP1 and MRP1 are overexpressed in melanoma, a skin cancer notoriously resistant to all current modalities of cancer therapy. To investigate the involvement of these detoxifying enzymes in the drug resistance of melanoma, an inducible (Tet-On system) antisense (AS) RNA strategy was used to specifically inhibit GSTP1 expression in A375 cells, a human melanoma...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-10-13)
More Articles from Gene Therapy Weekly
- DNA Vaccines
Method to recover plasmid DNA based on aqueous two-phase separation - Gene Therapy
Modified magnetic nanoparticles enhanced gene delivery of HVJ-E vector - Gene Therapy
Suppression of fat deposition for the lifetime with gene therapy - Vaccine Vectors
Signal in spleen necrosis virus does not allow efficient gene transfer - Vector Development
Nonviral vector for gene delivery and expression in brain developed - Alzheimer Disease
Targeting key enzyme with gene therapy reversed Alzheimer disease in mice - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
